Literature DB >> 17162396

Visceral artery aneurysms.

Yusuf Kalko1, Murat Ugurlucan, Murat Basaran, Eylul Kafali, Unal Aydin, Ulku Kafa, Taylan Kosker, Ozerdem Ozcaliskan, Erdal Yilmaz, Ufuk Alpagut, Tahsin Yasar, Enver Dayioglu.   

Abstract

OBJECTIVE: Visceral artery aneurysms are rare vascular malformations and the literature lacks satisfactory general information about the pathology. The aim of this study was to review our experiences in the diagnosis and treatment of visceral artery aneurysms.
MATERIALS AND METHODS: We retrospectively reviewed data on 10 patients who were diagnosed with visceral artery aneurysms at our institution between June 2002 and September 2005. All available clinical, pathologic, and postoperative data were reviewed and analyzed for postoperative outcome.
RESULTS: Four splenic artery aneurysms, 2 hepatic artery aneurysms, 5 renal artery aneurysms, 1 superior mesenteric artery aneurysm, and 1 inferior mesenteric artery aneurysm (13 total visceral artery aneurysms) were diagnosed in 10 patients. All the patients were treated except 1 patient with bilateral renal artery aneurysms. One patient required emergent surgical treatment due to splenic artery aneurysm rupture. Only 1 patient underwent endovascular treatment (ie, coil embolization for a superior mesenteric artery aneurysm); otherwise all the patients were treated surgically on an elective basis. Surgical treatment modalities included ligation with exclusion in 4 patients (2 splenic artery aneurysms, 1 renal artery aneurysm, 1 hepatic artery aneurysm) and resection with revascularization in 4 patients (1 splenic artery aneurysm, 2 renal artery aneurysms, 1 hepatic artery aneurysm, 1 inferior mesenteric artery aneurysm). Histopathologic examination of the vascular materials revealed major atherosclerotic changes except one that showed inflammatory vasculitic changes. One patient required bleeding revision, and mortality did not occur in any of the patients.
CONCLUSIONS: Visceral artery aneurysms are rare and potentially life-threatening vascular disorders. The number of cases diagnosed every year increases because of advanced radiologic diagnostic methods and screening programs. Careful consideration and early management of these malformations can be life saving.

Entities:  

Mesh:

Year:  2007        PMID: 17162396     DOI: 10.1532/HSF98.20061130

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  5 in total

1.  Collapse of a hockey player: ruptured aneurysm of the renal artery.

Authors:  Gavin W Smart; John S Crowley; Denis J Lavoie
Journal:  CMAJ       Date:  2010-03-29       Impact factor: 8.262

2.  Follow-up of true visceral artery aneurysm after coil embolization by three-dimensional contrast-enhanced MR angiography.

Authors:  Masamichi Koganemaru; Toshi Abe; Masaaki Nonoshita; Ryoji Iwamoto; Masashi Kusumoto; Asako Kuhara; Tomoko Kugiyama
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

3.  Visceral artery aneurysms--follow-up of 23 patients with 31 aneurysms after surgical or interventional therapy.

Authors:  Dirk Grotemeyer; Mansur Duran; Eun-Jo Park; Norbert Hoffmann; Dirk Blondin; Franziska Iskandar; Kai M Balzer; Wilhelm Sandmann
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

Review 4.  Successful Resection and Vascular Ligation of a Large Hepatic Artery Aneurysm - A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Iulian Brezean; Claudiu Anghel; Ion Barbu; Mihai Pautov; Irina Balescu; Vladislav Brasoveanu
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

5.  Rupture of Hepatic Pseudoaneurysm Formed Nine Years after Carbon Ion Radiotherapy for Hepatocellular Carcinoma.

Authors:  Shuhei Yoshikawa; Takeharu Asano; Mizuki Watanabe; Takehiro Ishii; Haruka Ohtake; Junichi Fujiwara; Masanari Sekine; Takeshi Uehara; Kohei Hamamoto; Kazuhito Yuhashi; Satohiro Matsumoto; Shinichi Asabe; Hiroyuki Miyatani; Katsuhiko Matsuura; Hirosato Mashima
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.